baber/WOPTO huggingface dataset:
Patent EP-1019117-B2 (EP)
Inventor: BENKOWSKI ROBERT J
IPC: A61M1/10
Filed: 1998-10-02
Granted: 2015-03-18
Abstract: A controller module for an implantable pump system which has a pump motor includes a processor, a motor controller electrically coupled to the processor and adapted to power the pump motor such that the pump motor operates at a desired speed. The motor controller outputs digital representations of the pump motor operating parameters to the processor. A first memory device is coupled to the processor for storing the digital signals representing the pump motor operating parameters. The controller module further includes a user interface. The controller module may be coupled to a data acquisition system, which provides power and exchanges data with the controller module. The controller module may alternately be coupled to a home support system which provides power for the controller module and storage for system components.
Patent EP-1047784-B2 (EP)
Inventor: MASIGNANI VEGA
IPC: A61K39/00
Filed: 1999-01-14
Granted: 2015-03-18
Abstract: The invention provides proteins from  Neisseria meningitidis  (strains A & B), including amino acid sequences, the corresponding nucleotide sequences, expression data, and serological data. The proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics.
Patent EP-1090033-B2 (EP)
Inventor: DEPLA ERIK
IPC: C12N7/01
Filed: 1999-06-23
Granted: 2007-12-19
Abstract: The present invention relates to HCV NS3 proteins and nucleic acids. In particular said HCV NS3 combines major epitopes correlating with the control of HCV infection. The HCV NS3 proteins and nucleic acids of the invention, or compositions comprising them are of use in prophylactic and therapeutic treatment of HCV infection. Specifically, the HCV NS3 proteins and nucleic acids are used in the preparation of a vaccine composition for the prophylactic and therapeutic treatment of HCV.
Patent EP-1141649-B2 (EP)
Inventor: CHIOU MINSHON J
IPC: F41H5/04
Filed: 1999-08-10
Granted: 2011-11-23
Abstract: A composite is disclosed which is resistant to knife and ice pick stab penetration and is made from a plurality of layers (12) of woven polybenzoxazole or polybenzothiazole fibers, a plurality of ballistic layers (16), and a plurality of tightly-woven penetration resistant layers (14). Said layers may comprise para-aramid fibers or polyethylene fibers.
Patent JP-H0380474-B2 (JP)
IPC: C12N5/00
Filed: 1981-06-30
Abstract: Antigens specific to respiratory syncytial virus are produced on the surface of cells by: (1) culturing in vitro cells derived from a human or animal mucosa, (2) inoculating the cultured cells with respiratory syncytial virus, and (3) selecting virally infected cells from the culture. The resulting cells or the viral antigen(s) when partially or completely isolated from the cells have immunological and diagnostic uses in respect of infection by respiratory syncytial virus and may be used to isolate viral antibodies. A specific cell strain NM7 produced by this method from bovine nasal mucosal cells has respiratory syncytial virus antigens on its surface and its corresponding, uninfected cell strain NM5 can be infected similarly.
Patent JP-2653381-B2 (JP)
IPC: C07C67/54
Filed: 1988-05-02
Granted: 1997-09-17
Abstract: Trialkylamines and methyl formate are recovered from reaction mixtures obtained in the preparation of trimethylolalkanes by reaction of n-alkanals with from 2.2 to 4.5 moles of formaldehyde in aqueous solution in the presence of from 0.6 to 3 mole of trialkylamine, each quantity based on 1 mole of alkanal, and subsequent hydrogenation in a process wherein the crude reaction mixture a) is heated to from 100 DEG  to 200 DEG  C., the water present in the reaction mixture is substantially separated off by distillation, together with any excess free trialkylamine, the trialkylamine present in the form of a trialkylammonium formate is freed to form a trimethylolalkane formate, the trialkylamine is distilled off and the trimethylolalkane formate is transesterified with methanol to trimethylolalkane and methyl formate in the presence or absence of a catalytic amount of an alkali metal alkoxide or alkaline earth metal alkoxide, or b) is substantially dewatered, any excess free trialkylamine being removed at the same time, the trialkylamine present in the form of a trialkylammonium formate is separated off by admixing the remaining mixture with methanol and heating the admixture to from 100 DEG  to 200 DEG  C. to form methyl formate and trialkylamine.
Patent JP-S6041076-B2 (JP)
IPC: C07D495/04
Filed: 1983-06-16
Abstract: This invention relates to a new thieno-pyridinone derivative of the formula:   <IMAGE>   and its pharmaceutically acceptable inorganic or organic acid addition salts. This invention relates also to a process for the preparation of said compound and to its therapeutic application as blood-platelet anti-aggregation agent and anti-thrombosis agent.
Patent JP-S6245802-B2 (JP)
IPC: B27K3/15
Filed: 1979-09-06
Abstract: An aqueous agent for treating wood and wooden materials, optionally containing customary additives, such as water-soluble wood protecting agents effective as insecticides and/or fungicides, comprises an organic binder drying by oxidation, said organic binder consisting essentially of the reaction product of an acid and a 1,3-butadiene substrate polymer modified to carry amino groups, wherein (1) the amino group carrying 1,3-butadiene polymer has a double bond content corresponding to an iodine number of at least 200 g iodine/100 g, of which a double bond content of at least 100, measured as iodine number, is derived from cis-1,4-structural elements of the 1,3-butadiene substrate polymer per se; (2) the amino group content of the amino group carrying 1,3-butadiene polymer is at least 50 mg-atoms of nitrogen/100 g of polymer; and (3) the 1,3-butadiene substrate polymer per se has at least 70 molar percent butadiene units and a molecular weight (Mn) of 500-6,000.
Patent JP-H0116573-B2 (JP)
IPC: B21D45/06
Filed: 1981-07-24
Abstract: This invention relates to a method of releasing a wall-ironed sleeve (6) having an enlarged wall thickness at the end remote from the sleeve bottom from a wall-ironing mandril is characterized in that a fluid is admitted at the transitional region between the normal wall thickness and the enlarged wall thickness.
Patent JP-2926328-B2 (JP)
IPC: C05G3/60
Filed: 1997-05-09
Granted: 1999-07-28
Abstract: A weed eradicating substance, and a desalination substance. A method of use includes irrigating the soil with water, prior to planting, to cause the germination of weed seeds, and thereafter applying a desalination agent to increase weed seed germination. An application of the inventive pesticide then causes a much larger number of weeds to be eradicated. An improved fertilizer and a method of making and using it, to enhance plant nutrient uptake. The improved fertilizer includes nitrogenous nutrients, and a desalination ingredient. In one form of the invention, a surfactant is also employed to improve the speed of the increased nutrient uptake ability of the plants.
Patent JP-3168215-B2 (JP)
IPC: A61K9/107
Filed: 1991-04-24
Granted: 2001-05-21
Abstract: The invention relates to a pharmacological product containing a polyelectrolyte complex, in particular a polyacid with a median particle size of less than 15  mu m and an active substance, which includes active peptides, proteins, enzymes, enzyme inhibitors, antigens, cytostatics, antiinflammatory agents, antibiotics and vaccines. The said product ensures that the active substance is converted in a non-damaging manner into a form which can be administered. In addition, there are beneficial effects on the biodistribution, bioavailability and absorption of the pharmaceutical composition.
Patent JP-H0757751-B2 (JP)
IPC: C07D405/06
Filed: 1987-05-29
Abstract: Certain trans-6-[2-(3- or 4-carboxamido-substitutedpyrrol-1-yl)alkyl]-4-hydroxypyran-2-ones and the corresponding ring-opened acids derived therefrom which are potent inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG CoA reductase) and are thus useful hypolipidemic or hypocholesterolemic agents. Pharmaceutical compositions containing such compounds, and a method of inhibiting the biosynthesis of cholesterol employing such pharmaceutical compositions are also disclosed.
Patent JP-3109861-B2 (JP)
IPC: G11C13/02
Filed: 1991-06-12
Granted: 2000-11-20
Abstract: The apparatus includes a recording medium (7-9,11,13) having a plurality of segmented planar electrodes (7-9), a plurality of probe electrodes (21-23) respectively facing the plural planar electrodes and electrically connected to each other, and a circuit (17) for independently applying a voltage for recording and/or reproducing between each pair of the planar electrodes and the probe electrodes. The information recording and/or reproducing apparatus includes a circuit for inputting information to be recorded into the recording medium, a memory (19,20) other than the recording medium for temporarily storing the input information, and a circuit (16) for applying the recording voltages between a plurality of probe electrodes and segmented planar electrodes in correspondence with the information stored in the memory.
Patent JP-S6129342-B2 (JP)
IPC: B29D99/00
Filed: 1980-10-14
Abstract: A series of 4-(2-hydroxyethylthiomethyl)pyridines and related compounds, and their pharmaceutically acceptable acid addition salts, having antiinflammatory and immunoregulatory activity are disclosed. Preferred compounds include 4-(2-hydroxyethylthiomethyl)pyridine itself, as well as 4-(2-hydroxyphenylthiomethyl)pyridine, 4-(2-hydroxy-1-propylthiomethyl)pyridine, 4-(3-hydroxy-2-butylthiomethyl)pyridine, 4-(2-hydroxyethylthiomethyl)pyrimidine, the acetate esters corresponding to the above compounds, and 4-(2,3-dihydroxy-1-propylthiomethyl)pyridine.
Patent JP-3245302-B2 (JP)
IPC: B65H5/06
Filed: 1994-07-01
Granted: 2002-01-15
Abstract: The present invention relates to an information processing apparatus having an information processing section for recording information on a sheet member or reading information therefrom. The information processing apparatus further has a platen disposed in the information processing section, a head member disposed opposite to the platen in the information processing section so as to record information on the sheet member or reading information therefrom, a conveyance mechanism for conveying the sheet member while passing it through the information processing section, and a conveyance passage displacement mechanism for displacing a conveyance passage for the sheet member by reciprocating between the platen side of the conveyance passage and the head member side thereof, the moving amount of the conveyance passage displacement mechanism being variable. The present invention thus can provides an information processing apparatus which can maintain a predetermined distance between the sheet member and the head member. <IMAGE>
Patent JP-H089635-B2 (JP)
IPC: C07K14/75
Filed: 1993-06-29
Abstract: The invention relates to peptide derivatives of formula (I): R1-A-Gly-Asp-Trp-R2 (I> in which R1, R2 and A are as defined in the description. Medications.
Patent JP-3483593-B2 (JP)
IPC: B31B50/66
Filed: 1993-07-15
Granted: 2004-01-06
Abstract: This apparatus has an anvil (23) supporting seal fins (21), a horn (35) consisting of a cylindrical portion and a forwardly convergent portion (35b), and a means for pressing the seal fins (21) against the anvil (23) via the front end of the horn (35) and transmitting ultrasonic vibration to the seal fins (21). The horn (35) is adapted to transmit ultrasonic vibration to a packaging material, fuse the sealant layers of the seal fins (21) to each other and seal the packaging material. An ultrasonic vibration absorption means is provided between the front end of the horn (35) and edge portions (25) of the seal fins (21) and adapted to absorb ultrasonic vibration. The seal fins (21) are excited when they receive ultrasonic vibration, and the ultrasonic vibration advancing toward the edge portions (25) is absorbed in the ultrasonic vibration absorption means, so that the ultrasonic vibration is not transmitted to the edge portions (25). Accordingly, dust does not occur in the end surfaces of paper substrates exposed at the edge portions (25) of the seal fins (21). <IMAGE>
Patent JP-H0755522-B2 (JP)
IPC: B29K67/00
Filed: 1990-07-05
Abstract: A surface-patterned, injection-molded article of polybutylene terephthalate is produced by placing a film composed mainly of a polybutylene resin and back-printed with a desired graphic and/or indicia pattern in a mold cavity so that the printed surface of the film will be in contact with resin to be injected thereinto. Molten resin composed mainly of polybutylene terephthalate is then injected into the mold cavity to bond the pattern-printed film integrally onto a corresponding surface of the resulting molded polybutylene terephthalate article.
Patent JP-2587063-B2 (JP)
IPC: B65B35/00
Filed: 1987-08-14
Granted: 1997-03-05
Abstract: A method and apparatus for placing multiple crimped flexible pieces (10) into concave formed shells (16). In the method, a plurality of flat fibrous web pieces are provided on a shuttle device and are picked up and crimped longitudinally by gripper fingers (12), and each piece is transferred laterally to a location over a formed shell then lowered and inserted into the shell. While the pieces are on the shuttle device they are moved apart from each other. Also, during lateral transfer the crimped pieces are moved longitudinally and are also bowed longitudinally while being placed into the concave formed shells. Suitable apparatus is also disclosed for picking up and crimping the flexible pieces and laterally transferring the pieces and placing them in the concave formed shells.
Patent JP-3101302-B2 (JP)
IPC: H04R3/02
Filed: 1990-07-30
Granted: 2000-10-23
Abstract: An active acoustic attenuation system (10) is provided with various adaptive filter models (40, 48, 56, 70, 84, 100) enabling communication between persons (26, 30) in spaced zones (12, 16) by selectively cancelling undesired noise and undesired speech, all on an on-line basis without dedicated off-line pretraining and also for both broadband and narrowband noise.
Patent JP-3782135-B2 (JP)
IPC: A61B17/00
Filed: 1995-08-18
Granted: 2006-06-07
Abstract: A surgical apparatus (1) is provided for manipulating a surgical needle (14) and an associated loading mechanism (70) is provided for replacing the surgical needle (14). The surgical apparatus (1) comprises an elongated body portion (3), first and second jaw elements (4,5) extending from the body portion (3), securing means for securing the surgical needle (14), releasing means cooperating with the securing means for releasing the surgical needle (14) and locking means cooperating with the securing means for preventing at least one of the jaw elements (4,5) from moving. A loading mechanism (70) is also provided and includes structure (78) for supporting a surgical needle (14) and a storage member (72) for retaining at least a portion of a length of suture material (18) attached to the surgical needle (14). <MATH>
Patent JP-H0690199-B2 (JP)
IPC: C12Q1/28
Filed: 1988-09-09
Abstract: The invention involves the use of a multiple oxidative indicator system capable of generating different hues at different concentrations of hydrogen peroxide or at different concentrations of an analyte from which hydrogen peroxide is generated by means of the analyte specific oxidase. At least one component of the multiple oxidative indicator system changes from a particular hue to a different hue upon oxidation. A second indicator component is capable of being oxidized to a form having a hue which is visually distinct from the first indicator component in either of its forms. The test compositions of this invention are capable of generating visually distinct hues at different concentrations of hydrogen peroxide and can be used to generate a "rainbow" in an oxidative system.
Patent JP-3389265-B2 (JP)
IPC: C07C13/28
Filed: 1992-08-25
Granted: 2003-03-24
Abstract: A highly effective catalyst system for the polymerisation of olefins comprises a cocatalyst, preferably an aluminoxane, and a metallocene of the formula (I) 
<IMAGE>
 in which, preferably, M<1> is Zr, R<1> and R<2> are an alkyl or halogen, R<3> to R<6> are alkyl, -(CR<8>R<9>)m-R<7>-(CR<8>R<9>)n- is a single- or multi-membered chain in which R<7> may also be a (substituted) heteroatom, and m + n is zero or 1. The catalyst system gives polymers of variable molecular weight and stereotacticity, depending on the selected substituents R<3> to R<6>, at industrially relevant polymerisation temperatures.
Patent JP-4106134-B2 (JP)
IPC: C08G18/18
Filed: 1998-08-04
Granted: 2008-06-25
Abstract: Production of polyisocyanates is new, in which isocyanates of formula (OCN-CH2)X (I) are obtained by polymerisation in the presence of hydrogen polyfluorides of formula (II) as oligomerisation catalysts, in which X = optionally branched, optionally cyclic 3-20C groups containing at least one other NCO group and optionally other hetero atoms or groups (N, O, S); m = 0.1 or more; and M = n-charged cation(s). Also claimed are the products obtained by this process.
Patent JP-3249594-B2 (JP)
IPC: B01D71/42
Filed: 1992-08-31
Granted: 2002-01-21
Abstract: A composite membrane comprises a substrate made from a polymer selected from copolymers and homopolymers of ethylenically unsaturated nitriles, which substrate has preferably first been treated with a pore protector in absence of curing agents and catalysts therefor, prior to applying as the final coating a silicone layer, which is crosslinked. The pore protector, which may be, for example, a hydroxy-terminated polysiloxane, particularly a silanol-terminated polysiloxane, serves the dual purpose of preventing the pores from collapsing, when the support is dried during the curing of the silicone layer, and of preventing passage of the coating material deeply into the pores and thus also preventing an undue reduction of the flux of the finished coated membrane. Such composite membranes include solvent stable membranes which swell to an extent of no more than about 10% when immersed in various organic solvents, and their mixtures with each other and/or water.
Patent JP-2863212-B2 (JP)
IPC: H04W64/00
Filed: 1989-10-06
Granted: 1999-03-03
Abstract: PURPOSE:To prevent the deterioration of the using efficiency of a control channel by sending out simultaneously information having different contents at every sector, and deciding present available sector by the result of receiving its information by each moving station in a radio zone. CONSTITUTION:A control channel signal is constituted of a simultaneous transmission part in which the information contents are all the same in sectors in a zone and a simultaneous transmission part having the different information contents at every sector. A mobile station recognizes its own available zone by scanning a control channel frequency stored in a nonvolatile memory provided on the mobile station at the time of the start of a power source, and measuring and comparing a receiving level. Subsequently, the simultaneous transmission part having the different information contents at every sector of a control channel is received, and the sector corresponding to its contents is decided as an available sector. In such a manner, the mobile station can decide the sector of the available zone of its own station with satisfactory accuracy without deteriorating the using efficiency of the control channel.
Patent JP-4038830-B2 (JP)
IPC: F25B1/00
Filed: 1996-10-04
Granted: 2008-01-30
Abstract: PROBLEM TO BE SOLVED: To avoid dangers of an outbreak of fire and explosion when a refrigerant leaks in a refrigerant using a combustible refrigerant by opening a ventilating hole provided in a heat insulating box when a refrigerant leakage detector provided in the heat insulating box detects the refrigerant leakage. SOLUTION: Irrespective of a refrigerator being operated or interrupted, if a refrigerant leakage detector 12 or 13 detects refrigerant leakage, a controller sends to a ventilating hole cover driving apparatus and a ventilating fan driving apparatus an instruction of starting of ventilation. The ventilating hole cover 17 is adapted such that its surface in contact with a heat insulation box 1 is a cylindrical one or a spherical one, and the ventilating hole driving apparatus is located at the center of the cylindrical surface or the spherical surface. Once the controller receives the instruction of starting of ventilation, the ventilating hole driving apparatus rotates the ventilating hole cover 17 by 90 degree anticlockwise with itself taken as the center to communicate the refrigerator and the outside of the refrigerator.  Simultaneously, the ventilating fan driving apparatus starts the fan 18 to discharge leaked refrigerant to the outside of the refrigerator.
Patent JP-3695171-B2 (JP)
IPC: F16D65/18
Filed: 1998-09-18
Granted: 2005-09-14
Abstract: PROBLEM TO BE SOLVED: To perform accurate control in various current control of an electric motor in a motor-driven braking device for a vehicle. SOLUTION: This braking device is provided with a pad disposed opposedly to a disc rotated integrally with a wheel, and an electric motor for pressing the pad to the disc through a driving member to apply braking force to the wheel. In the stop state of the electric motor, the driving current of the electric motor is gradually increased (step 222). In the gradually increased state of the driving current, the driving current at the time of the electric motor starting its rotating action is determined as the minimum driving current of the electric motor (step 214-220, 224). Even with the change of environment in which the braking device is placed, the minimum driving current corresponding to the environment is detected, and the electric motor is current-controlled using the minimum driving current, so that the current control can be performed always accurately.
Patent JP-H0812048-B2 (JP)
IPC: G01D5/38
Filed: 1991-10-17
Abstract: In such a measuring device for measuring the relative position of objects, the collimated light beam (L) emanating from a light source (3) is split at a first scanning grating (7) into three diffraction rays (B1-B3) (<+>1st, 0th order) in the at least one measuring direction (X). These three diffraction rays (B1-B3) are divided at a cross grating (11) of a scale into eight diffraction rays (C1-C8) (<+>1st order), and are brought to interference at a second scanning grating (7) with renewed diffraction; the resulting diffraction rays (E1-E6) impinge on detectors (D1-D6) for generating measured values for the at least one measuring direction (X). The cross graduation (11) of the scale extends diagonally to the at least one measuring direction (X) and has in the measuring direction (X) an effective grating constant de which is in agreement with the grating constant d of the scanning grating (7). The detectors (D1-D6) are arranged such that only diffraction rays (E1-E6) are detected which are deflected by the cross grating (11) in the measuring direction (X) and in the direction (Y) perpendicular thereto.
Patent JP-2700881-B2 (JP)
IPC: A61L27/00
Filed: 1986-12-05
Granted: 1998-01-21
Abstract: The invention relates to an implantable medicament depot comprising physiologically acceptable excipients and at least one delayed release active compound which is a chemotherapeutic of the gyrase inhibitor type. The depot can be used for combating infections.